HighTower Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-49,831
| Closed | -$5K | – | 2486 |
|
|
2018
Q4 | $5K | Sell |
49,831
-1,825,297
| -97% | -$1.2M | ﹤0.01% | 2149 |
|
|
2018
Q3 | $3.18M | Buy |
1,875,128
+966,182
| +106% | +$1.73M | 0.02% | 668 |
|
|
2018
Q2 | $1.58M | Sell |
908,946
-5,112
| -0.6% | -$8.84K | 0.01% | 939 |
|
|
2018
Q1 | $1.67M | Buy |
914,058
+111,076
| +14% | +$235K | 0.01% | 868 |
|
|
2017
Q4 | $1.78M | Sell |
802,982
-42,282
| -5% | -$105K | 0.01% | 862 |
|
|
2017
Q3 | $2.44M | Buy |
845,264
+40,758
| +5% | +$139K | 0.02% | 753 |
|
|
2017
Q2 | $3.57M | Buy |
804,506
+89,458
| +13% | +$369K | 0.03% | 591 |
|
|
2017
Q1 | $3.33M | Sell |
715,048
-109,901
| -13% | -$637K | 0.03% | 574 |
|
|
2016
Q4 | $5.02M | Sell |
824,949
-80,815
| -9% | -$422K | 0.05% | 384 |
|
|
2016
Q3 | $4.99M | Sell |
905,764
-984
| -0.1% | -$4.61K | 0.06% | 357 |
|
|
2016
Q2 | $3.44M | Buy |
906,748
+47,139
| +5% | +$160K | 0.04% | 447 |
|
|
2016
Q1 | $2.37M | Buy |
859,609
+714,615
| +493% | +$2.59M | 0.01% | 661 |
|
|
2015
Q4 | $821K | Sell |
144,994
-157,322
| -52% | -$959K | 0.01% | 1076 |
|
|
2015
Q3 | $1.6M | Buy |
302,316
+229,538
| +315% | +$1.78M | 0.02% | 695 |
|
|
2015
Q2 | $604K | Sell |
72,778
-219,256
| -75% | -$1.06M | 0.01% | 958 |
|
|
2015
Q1 | $1.35M | Sell |
292,034
-272,393
| -48% | -$886K | 0.02% | 710 |
|
|
2014
Q4 | $1.72M | Buy |
564,427
+197,326
| +54% | +$584K | 0.03% | 639 |
|
|
2014
Q3 | $1.02M | Buy |
367,101
+31,369
| +9% | +$114K | 0.02% | 768 |
|
|
2014
Q2 | $1.37M | Sell |
335,732
-18,294
| -5% | -$77.7K | 0.02% | 695 |
|
|
2014
Q1 | $1.88M | Buy |
354,026
+92,728
| +35% | +$520K | 0.04% | 532 |
|
|
2013
Q4 | $1.45M | Buy |
261,298
+15,909
| +6% | +$68.6K | 0.03% | 576 |
|
|
2013
Q3 | $1.11M | Buy |
245,389
+88,131
| +56% | +$395K | 0.03% | 598 |
|
|
2013
Q2 | $670K | Buy |
+157,258
| New | +$790K | 0.02% | 718 |
|
Other funds holding SGYP
HighTower Advisors's SGYP Position: Q1 2019 in Review
HighTower Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 49,831 shares — an estimated $5K sold.
HighTower Advisors first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $5.02M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- HighTower Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- HighTower Advisors sold 49,831 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $5K.
- HighTower Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- HighTower Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $5.02M in Q4 2016.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on HighTower Advisors's 13F filing for Q1 2019, filed 15 May 2019.